
Rectal cancer drug trial of dostarlimab cures all patients: report
Fox News
A clinical trial of dostarlimab, done by Memorial Sloan Kettering Cancer Center, found the drug appears to have completely cured 12 patients of rectal cancer.
"Longer follow-up is needed to assess the duration of response." Ann W. Schmidt is a lifestyle reporter and editor for Fox News Digital.
That's according to a paper published on Sunday in the New England Journal of Medicine.
The patients took dostarlimab every three weeks for six months and had at least another six months of follow-up treatment, the paper said.
More Related News

Pizza before tomatoes? Ancient Rome's version of America's favorite food looked nothing like today's
Ancient Rome pizza at Hungary restaurant features no tomatoes or mozzarella, using garum fish sauce and olive paste. Neverland Pizzeria's dish is limited-edition.












